Linqmed
Chiba
About Linqmed
Linqmed is a pharmaceutical company that specializes in the research and development of radiopharmaceuticals for cancer treatment.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $32.2M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2025)
- Website: linqmed.co.jp
- Phone: [email protected]
Industries & Categories
Health Care, Health Diagnostics, Medical, Oncology, Pharmaceutical
Canonical: https://fsome.com/organization/linqmed-21917 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.